CA - Bausch Health gains amid win in Norwich case over generic Xifaxan
2023-11-01 11:03:02 ET
More on Bausch Health Companies
- Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics
- Bausch Health Companies Inc. (BHC) Q2 2023 Earnings Call Transcript
- Bausch Health gets FDA approval for acne treatment Cabtreo
- Bausch Health stock rebounds from Tuesday sell-off, helped by Jefferies upgrade
- Seeking Alpha’s Quant Rating on Bausch Health Companies
For further details see:
Bausch Health gains amid win in Norwich case over generic Xifaxan